Yıl: 2018 Cilt: 5 Sayı: 3 Sayfa Aralığı: 1387 - 1398 Metin Dili: İngilizce İndeks Tarihi: 29-02-2020

QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562)

Öz:
This research applied Quantitative Structure Activity Relationship (QSAR) technique indeveloping a Multiple-Linear Regression (MLR) model using Genetic Functional Approximation (GFA)method in selecting optimum molecular descriptors from the structures of 24 C14-urea tetrandrinecompounds. Firstly, the compounds were optimized at the Density Functional Theory (DFT) level usingBecke’s three-parameter Lee-Yang-Parr hybrid functional (B3LYP) with the 6-31G* basis set in theSpartan 14 Version 1.1.4 software. The descriptors of the compounds were computed using Padelsoftware,and data set was divided into training and test set. A model was built from the training setwith internal validation parameter R2train as 0.9104. The external validation of the model was done usingthe test set compounds with validation parameter R2test as 0.6443 that passed the criteria foracceptability of a QSAR model globally. The coefficient of determination (𝑐𝑅2𝑝) parameter was calculatedas 0.8192 which is greater than 0.5, this affirms that the generated model is robust. Furthermore,AST4p, GATS8v, and MLFER are descriptors in the model with the positive mean effect of 0.0899, 0.9098and 0.0002 respectively. This study depicts a route in designing and synthesizing new C14-ureatetrandrine compounds with better inhibitory potentials.
Anahtar Kelime:

Konular: Kimya, Analitik Termodinamik Spektroskopi Kimya, Uygulamalı Kimya, Organik Kimya, Tıbbi Fizikokimya Kimya, İnorganik ve Nükleer
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lookward W. Leukemia (AML, CML, ALL and CLL). www.RN.ORG; ©RN.ORG®, S.A., RN.ORG®, LL; 2015. ISBN: 678-693-1-32.
  • 2. Lozzio CB, Lozzio BB. Human Chronic Myelogenous Leukemia Cell-Line with Positive Philadelphia Chromosome. National Institute of Health. 1975; 45(1): 321–340.
  • 3. Karimiani EG, Marriage F, Merritt AJ, Burthem J, Byers RJ, Day PJ. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Experimental Hematology. 2014; 42(3): 183-191
  • 4. Fan Y, Lu H, An L, Wang C, Zhou Z, Feng F, Zhao Q. Effect of active fraction of Eriocaulon sieboldianum on human leukemia K562 cells via proliferation inhibition, cell cycle arrest and apoptosis induction. Environmental Toxicology and Pharmacology. 2016; 4(3):13-20.
  • 5. Liu T, Liu X, Li WH. Tetrandrine, a Chinese Plant-Derived Alkaloid, Is a Potential Candidate for Cancer Chemotherapy, On Co-Target. 2016; 2(7):480100–480115.
  • 6. Perkins R, Fang H, Tong W, Welsh WJ. Quantitative Structure-Activity Relationship Methods: Perspectives on Drug Discovery and Toxicology. 2003; 22(1): 1666–1679.
  • 7. Lan J, Huang L, Lou H, Chen C, Liu T, Hu S, Yao Y, Song J, Luo J, Liu Y, Xia B, Xia L, Zeng X, Ben-David Y, Pan W. Design and Synthesis of Novel Tetrandrine Derivatives as Potential Anti- Tumor Agents against Human Hepatocellular Carcinoma. European Journal of Medicinal Chemistry. 2017 Sep; 3-4.
  • 8. Becke AD. Becke’s three-parameter hybrid method using the LYP correlation functional. Journal of Chemical Physics. 1993; 98: 5648– 5652.
  • 9. Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B. 1988; 37:785
  • 10. Alisi IO, Uzairu A, Abechi SE, Idris SO. Quantitative Structure activity relationship analysis of coumarins as free radical scavengers by genetic function algorithm. Iranian Chemical Society. 2018 Mar; 2(6):208–222
  • 11. Ambure P, Rahul BA, Agnieszka G, Tomasz P, Kunal R. “NanoBRIDGES” Software: Open Access Tools to Perform QSAR and Nano-QSAR Modeling. Chemical Intelligent Laboratory Systems. 2015; 147: 1–13.
  • 12. Kennard RW, Stone LA. Computer Aided Design of Experiments. Technometrics. 1969 Feb; 11(1):137–48.
  • 13. Friedman JH, Multivariate Adaptive Regression Splines. The Annals of Statistics. 1991: 1–67.
  • 14. Khaled KF, Abdel-Shafi NS. Quantitative structure and activity relationship modeling study of corrosion inhibitors: Genetic function approximation and molecular dynamics simulation methods. International Journal of Electrochemical Science. 2011; 6:4077-4094
  • 15. Brand V, Orr KA, Comprehensive R archive network (CRAN):http://CRAN.Rproject.org. retrieved; 2015
  • 16. Tropsha A. Best Practices for QSAR Model Development, Validation, and Exploitation. Molecular Informatics. 2010 Jul 6; 29(6– 7):476–88.
  • 17. Minovski N, Župerl Š, Drgan V, Novič M. Assessment of applicability domain for multivariate counter-propagation artificial neural network predictive models by minimum Euclidean distance space analysis: a case study. Analytica Chimica Acta. 2013; 759:28–42.
  • 18. Myers RH. Classical and modern regression application. 2nd edition. Duxbury Press. CA. 1990
  • 19. Eriksson L, Jaworska J, Worth AP, Cronin MTD, McDowell RM, Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-baes QSARs. Environmental Health Perspectives 2003; 111:1361-1375
  • 20. Nandi S, Monesi A, Drgan V, Merzel F, Novič M. Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors. Chemistry Central Journal. 2013; 7:1-13.
  • 21. Gramatica P, Giani E., Papa E., Statistical external validation and consensus modeling: A QSPR case study for KOC prediction. Journal of Molecular Graphics and Modelling. 2007; 25:755-66.
  • 22. Todeschini R, Consonni V. Molecular descriptors for chemo-informatics. Weinheim: Wiley- VCH; 2009. (Methods and principles in medicinal chemistry). ISBN: 9783527318520
  • 23. Adeniji SE, Sani U, Uzairu A, QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium Tuberculosis Receptor (Mtb CYP121). Journal of Pathogens Hindawi. 2018; 24-64.
APA Mustapha A, Shallangwa G, IBRAHIM M, BELLO A, ARTHUR D, Uzairu A, MAMZA P (2018). QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). , 1387 - 1398.
Chicago Mustapha Abdullahi,Shallangwa Gideon Adamu,IBRAHIM Muhammad Tukur,BELLO Abdullahi Umar,ARTHUR David Ebuka,Uzairu Adamu,MAMZA Paul QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). (2018): 1387 - 1398.
MLA Mustapha Abdullahi,Shallangwa Gideon Adamu,IBRAHIM Muhammad Tukur,BELLO Abdullahi Umar,ARTHUR David Ebuka,Uzairu Adamu,MAMZA Paul QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). , 2018, ss.1387 - 1398.
AMA Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). . 2018; 1387 - 1398.
Vancouver Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). . 2018; 1387 - 1398.
IEEE Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P "QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562)." , ss.1387 - 1398, 2018.
ISNAD Mustapha, Abdullahi vd. "QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562)". (2018), 1387-1398.
APA Mustapha A, Shallangwa G, IBRAHIM M, BELLO A, ARTHUR D, Uzairu A, MAMZA P (2018). QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). Journal of the Turkish Chemical Society, Section A: Chemistry, 5(3), 1387 - 1398.
Chicago Mustapha Abdullahi,Shallangwa Gideon Adamu,IBRAHIM Muhammad Tukur,BELLO Abdullahi Umar,ARTHUR David Ebuka,Uzairu Adamu,MAMZA Paul QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). Journal of the Turkish Chemical Society, Section A: Chemistry 5, no.3 (2018): 1387 - 1398.
MLA Mustapha Abdullahi,Shallangwa Gideon Adamu,IBRAHIM Muhammad Tukur,BELLO Abdullahi Umar,ARTHUR David Ebuka,Uzairu Adamu,MAMZA Paul QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). Journal of the Turkish Chemical Society, Section A: Chemistry, vol.5, no.3, 2018, ss.1387 - 1398.
AMA Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). Journal of the Turkish Chemical Society, Section A: Chemistry. 2018; 5(3): 1387 - 1398.
Vancouver Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562). Journal of the Turkish Chemical Society, Section A: Chemistry. 2018; 5(3): 1387 - 1398.
IEEE Mustapha A,Shallangwa G,IBRAHIM M,BELLO A,ARTHUR D,Uzairu A,MAMZA P "QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562)." Journal of the Turkish Chemical Society, Section A: Chemistry, 5, ss.1387 - 1398, 2018.
ISNAD Mustapha, Abdullahi vd. "QSAR studies on some $C14$-urea tetrandrine compounds as potent anti-cancer agents against Leukemia cell line (K562)". Journal of the Turkish Chemical Society, Section A: Chemistry 5/3 (2018), 1387-1398.